These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16610051

  • 1. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
    Naito Y, Katada K, Takagi T, Tsuboi H, Kuroda M, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T.
    World J Gastroenterol; 2006 Apr 07; 12(13):2024-30. PubMed ID: 16610051
    [Abstract] [Full Text] [Related]

  • 2. A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats.
    Naito Y, Takagi T, Ichikawa H, Tomatsuri N, Kuroda M, Isozaki Y, Katada K, Uchiyama K, Kokura S, Yoshida N, Okanoue T, Yoshikawa T.
    Nitric Oxide; 2004 May 07; 10(3):170-7. PubMed ID: 15158697
    [Abstract] [Full Text] [Related]

  • 3. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    Matsuo S, Saiki Y, Adachi O, Kawamoto S, Fukushige S, Horii A, Saiki Y.
    J Thorac Cardiovasc Surg; 2015 Mar 07; 149(3):902-9. PubMed ID: 25454916
    [Abstract] [Full Text] [Related]

  • 4. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
    Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T.
    Int J Mol Med; 2006 Jun 07; 17(6):997-1004. PubMed ID: 16685407
    [Abstract] [Full Text] [Related]

  • 5. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
    Die J, Wang K, Fan L, Jiang Y, Shi Z.
    Brain Res; 2010 Jul 30; 1346():251-61. PubMed ID: 20513366
    [Abstract] [Full Text] [Related]

  • 6. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.
    Weinberg EO, Scherrer-Crosbie M, Picard MH, Nasseri BA, MacGillivray C, Gannon J, Lian Q, Bloch KD, Lee RT.
    Am J Physiol Heart Circ Physiol; 2005 Apr 30; 288(4):H1802-9. PubMed ID: 15563531
    [Abstract] [Full Text] [Related]

  • 7. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
    Burma O, Onat E, Uysal A, Ilhan N, Erol D, Ozcan M, Sahna E.
    Cardiovasc J Afr; 2014 Apr 30; 25(5):212-6. PubMed ID: 25629537
    [Abstract] [Full Text] [Related]

  • 8. Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.
    Ichikawa H, Yoshida N, Takagi T, Tomatsuri N, Katada K, Isozaki Y, Uchiyama K, Naito Y, Okanoue T, Yoshikawa T.
    World J Gastroenterol; 2004 Oct 01; 10(19):2814-7. PubMed ID: 15334676
    [Abstract] [Full Text] [Related]

  • 9. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P, Taccardi AA, Grilli A, De Lutiis MA, Barsotti A, Felaco M, De Caterina R.
    Cardiovasc Res; 2005 Jun 01; 66(3):462-71. PubMed ID: 15914111
    [Abstract] [Full Text] [Related]

  • 10. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M.
    Brain Res; 2002 Jun 28; 942(1-2):23-30. PubMed ID: 12031849
    [Abstract] [Full Text] [Related]

  • 11. Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats.
    Tsuboi H, Naito Y, Katada K, Takagi T, Handa O, Kokura S, Ichikawa H, Yoshida N, Tsukada M, Yoshikawa T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb 28; 292(2):G678-83. PubMed ID: 17023547
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
    Wu N, Li W, Lv Y, Shu W, Jia D.
    Pharmazie; 2014 Sep 28; 69(9):704-8. PubMed ID: 25272944
    [Abstract] [Full Text] [Related]

  • 13. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats.
    Takagi T, Yoshida N, Isozaki Y, Shimozawa M, Katada K, Manabe H, Hanada O, Kokura S, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):283-90. PubMed ID: 16545368
    [Abstract] [Full Text] [Related]

  • 14. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.
    Jones SP, Gibson MF, Rimmer DM, Gibson TM, Sharp BR, Lefer DJ.
    J Am Coll Cardiol; 2002 Sep 18; 40(6):1172-8. PubMed ID: 12354446
    [Abstract] [Full Text] [Related]

  • 15. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.
    Bulhak A, Roy J, Hedin U, Sjöquist PO, Pernow J.
    Am J Physiol Heart Circ Physiol; 2007 Jun 18; 292(6):H3158-63. PubMed ID: 17322412
    [Abstract] [Full Text] [Related]

  • 16. Rosuvastatin may have neuroprotective effect on spinal cord ischemia reperfusion injury.
    Yavuz C, Demirtas S, Guclu O, Karahan O, Caliskan A, Yazici S, Mavitas B.
    CNS Neurol Disord Drug Targets; 2013 Nov 18; 12(7):1011-6. PubMed ID: 23844682
    [Abstract] [Full Text] [Related]

  • 17. Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.
    Li X, Yang G, Zhao G, Wu B, Edin ML, Zeldin DC, Wang DW.
    Hypertens Res; 2011 Jul 18; 34(7):869-75. PubMed ID: 21562509
    [Abstract] [Full Text] [Related]

  • 18. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Sironi L, Gianazza E, Gelosa P, Guerrini U, Nobili E, Gianella A, Cremonesi B, Paoletti R, Tremoli E.
    Arterioscler Thromb Vasc Biol; 2005 Mar 18; 25(3):598-603. PubMed ID: 15681303
    [Abstract] [Full Text] [Related]

  • 19. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y, Yamaguchi K, Nakajima T, Nishikawa T, Jo M, Mitsumoto Y, Kimura H, Nishimura T, Tochiki N, Yasui K, Mitsuyoshi H, Minami M, Kagawa K, Okanoue T, Itoh Y.
    Liver Int; 2013 Feb 18; 33(2):301-11. PubMed ID: 23295058
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.